BioSpace News Archive

InsightRX, a pioneer in precision medicine, today announced it has been named a finalist in the 2019 Accenture HealthTech Innovation Challenge.

This Webcast will be available for replay until February 21, 2020.

Most recently, she served as Principal and Founder of Two Blue Consulting with clients that included Johnson and Johnson, Pfizer, BioPhotas, Afecta Pharmaceuticals, and VI Aesthetics, as well as a variety of startup companies.

Medicare Supplement plans of the same type (Plan A, for example) offered by different insurers may vary significantly from one another in terms of premium while providing the same basic benefits and levels of coverage.

Chief Executive Officer David L. Lucchino will present a Company overview at the 38th annual J.P. Morgan Healthcare conference.

MS affects nearly 1 million adults in the United States and an estimated 2.3 million individuals worldwide.

ILS will be adding new sites to broaden Principal Investigator (PI) and participant representation in Australia.

Concurrent with the transactions, Jim Wachtman has joined as Chief Executive Officer.

Novome Biotechnologies, Inc., a biotechnology company engineering first-in-class, living medicines for chronic diseases, today announced that it has secured $33 million in a Series A financing and has appointed Blake Wise as Chief Executive Officer

Aligos Therapeutics, a pre-clinical stage biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis B (CHB), nonalcoholic steatohepatitis (NASH), and hepatocellular carcinoma (HCC), today announced that CEO Lawrence Blatt, Ph.D., MBA, will present at the 38th Annual J.P. Morgan Healthcare Conference